ArticleCancer immunology research2024

RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma.

Pengfei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.